A 125th Anniversary. A celebration marking such an anniversary. A mouthful.
Thank you Oregonians for supporting OHSU in our pursuit to translate complex information into better health since 1887. Because of you we have been able to build a world-class academic health center where healing, teaching and discovery come together every day to improve the health of people in Oregon — and around the world.
In October 1887, the University of Oregon established a department of medicine in Northwest Portland. Since those first building blocks were laid down, the university has dramatically expanded both in form and function, but its core values and mission remain the same.
Today, OHSU is the sum of our community's 125 years of support and commitment to creating a world-class academic health center. "Imagine the future with us" was a lecture series throughout the 2012-13 academic year to mark the 125th anniversary of the OHSU School of Medicine. We invited our community to think creatively about the future and the future of our integrated missions of discovery, health care, education and outreach. It was an honor to host the following speakers who helped catalyze this conversation.
Juan Enriquez conducted a special seminar for faculty, students and staff. The seminar was in advance of Enriquez's keynote lecture at the Portland Art Museum, "The Future Body." A leading authority on the economic impact of life sciences on business and society and an internationally known business leader and entrepreneur, Enriquez is a broad thinker. He is managing director of Excel Venture Management. Prior to this, Enriquez was the founding director of the Harvard Business School's Life Sciences Project. Many of his innovative thoughts are captured in his bestselling book, As The Future Catches You, which provided a blueprint of how a bio-based economy changes industries and corporations. His most recent publication is an eBook, Homo Evolutis: A Short Tour of our New Species, which describes a world where humans increasingly shape their environment, themselves and other species.
Eric Dishman shared his perspective on how technology will reshape health care delivery, and even the definition of health care. Dishman is widely recognized as a global leader in health care innovation, user-centered design, and home and community-based technologies. Dishman founded Intel's first health care lab in 1999 and co-founded the Intel Digital Health Group. Trained as a social scientist, he leads an interdisciplinary team who builds upon Intel's 12-year study of the needs of over 1,000 patients and hundreds of clinicians in 20 countries to inform Intel's innovation and policy efforts.
Amanda Bennett tells powerful stories that catalyze change. She directs special projects and investigations for Bloomberg News, and is the former co-chair of the Pulitzer Prize Board. Bennett previously served as editor of The Philadelphia Inquirer, editor of the Herald-Leader (Lexington, KY), managing editor for The Oregonian, and Atlanta Bureau chief (among numerous other posts) at The Wall Street Journal. In 1997 Bennett shared the Pulitzer Prize for national reporting with her Journal colleagues, and in 2001 she led an Oregonian team to a Pulitzer for public service. Most recently, she has published The Cost of Hope (Random House), chronicling her experiences in the health care system. In his review, Bill Gates called The Cost of Hope "...a perfect example about why all of the hard decisions about health care spending are just that."
Alan Guttmacher, M.D., helped us explore the ethical, legal and social implications of human genomics. He is the director of the National Institute of Child Health and Development (NICHD). A pediatrician and medical geneticist, Dr. Guttmacher previously worked at the National Human Genome Research Institute (NHGRI), where he served in a number of roles and oversaw that Institute's efforts to advance genome research. As part of this, Dr. Guttmacher established a dialogue with health professionals and the public about the health and societal implications of the Human Genome Project. Dr. Guttmacher is a fellow of the American Academy of Pediatrics and a member of the Institute of Medicine.
George Mejicano, M.D., M.S., shared his vision for the education mission in the School of Medicine. In his role as senior associate dean for education, Dr. Mejicano is part of an mission-integrated senior leadership team in the School of Medicine, which reflects the school's commitment to collaboration and partnerships across all missions. Dr. Mejicano has received numerous awards for leadership and teaching and has served in many national leadership positions, including service on the Board of Directors of the Accreditation Council for Continuing Medical Education and the Board of Scientific Counselors of the National Center for Infectious Diseases of the U.S. Centers for Disease Control and Prevention. Dr. Mejicano joined OHSU from the University of Wisconsin School of Medicine and Public Health, where he was associate dean for continuing professional development and the director of the Office of Continuing Professional Development.
Mace L. Rothenberg, M.D., led us in a conversation about the future of academic-industry partnerships in discovery. Dr. Rothenberg is responsible for overseeing clinical research and development activities as well as post-marketing evaluation and monitoring for all Pfizer oncology products. Dr. Rothenberg came to Pfizer in 2008 after more than 20 years in academia where he focused on early-stage drug development, clinical trial design, and the coordinated laboratory-clinical evaluation of new therapies for gastrointestinal cancers. He is the recipient of the American Cancer Society's Lane W. Adams Quality of Life Award, honoring him as one of the nation's top cancer caregivers and the American Society of Clinical Oncology's Statesman Award, honoring him for more than 20 years of service to the organization, the specialty of oncology and cancer patients.
Professor Sir Bruce Ponder joined us for a conversation about the future of cancer research and treatment. Dr. Ponder is director and professor of oncology at the Cancer Research UK Cambridge Research Institute. He is world-renowned for his pioneering research into discovering genes that affect our risk of common cancers, particularly breast cancer. He is also investigating the genetics of esophageal cancer. Dr. Ponder's team helped to identify the breast cancer susceptibility genes BRCA1 and BRCA2.
The Lecture Series also included a special presentation that looked back at our rich history.
John Benson, M.D., OHSU School of Medicine dean emeritus, was a speaker in the History of Medicine Society lecture series. This special lecture was held April 12, 2013, in the OHSU Auditorium. For more information, visit the Historical Collections & Archives lecture website. An educator and clinician, Dr. Benson became a faculty member at the School of Medicine in 1959. During his 18 years at OHSU, Dr. Benson was instrumental to the development of the Division of Gastroenterology, served on the OHSU Center for Ethics in Health Care, and was interim dean of the School of Medicine from 1992 to 1994. The annual Benson/Kendall Visiting Professorship lecture is named in his honor, along with John Kendall, Jr., M.D., for outstanding years served at the OHSU School of Medicine.